Hypoxic Control of Metastasis

Overview

Journal Science

Specialty Science

Date 2016 Apr 29

PMID 27124451

Citations 593

Authors

Erinn B Rankin

Amato J Giaccia

Affiliations

Soon will be listed here.

Abstract

Metastatic disease is the leading cause of cancer-related deaths and involves critical interactions between tumor cells and the microenvironment. Hypoxia is a potent microenvironmental factor promoting metastatic progression. Clinically, hypoxia and the expression of the hypoxia-inducible transcription factors HIF-1 and HIF-2 are associated with increased distant metastasis and poor survival in a variety of tumor types. Moreover, HIF signaling in malignant cells influences multiple steps within the metastatic cascade. Here we review research focused on elucidating the mechanisms by which the hypoxic tumor microenvironment promotes metastatic progression. These studies have identified potential biomarkers and therapeutic targets regulated by hypoxia that could be incorporated into strategies aimed at preventing and treating metastatic disease.

Citing Articles

Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance.

Xiao Y, Hassani M, Moghaddam M, Fazilat A, Ojarudi M, Valilo M Med Oncol. 2025; 42(4):108.

PMID: 40087196 DOI: 10.1007/s12032-025-02675-8.

NINJ1 in Cell Death and Ferroptosis: Implications for Tumor Invasion and Metastasis.

Chen S, Shyu I, Chi J Cancers (Basel). 2025; 17(5).

PMID: 40075648 PMC: 11898531. DOI: 10.3390/cancers17050800.

The role of tumor-derived exosomal LncRNA in tumor metastasis.

Yu Z, Fu J, Mantareva V, Blazevic I, Wu Y, Wen D Cancer Gene Ther. 2025; .

PMID: 40011710 DOI: 10.1038/s41417-024-00852-x.

Clinical and Prognostic Value of VHL in Korean Patients with Rectal Cancer.

Moon S, Lee J, Lee J, Kim T, Park J Medicina (Kaunas). 2025; 61(2).

PMID: 40005423 PMC: 11857133. DOI: 10.3390/medicina61020306.

Landscape of Noncoding RNA in the Hypoxic Tumor Microenvironment.

Gong L, Zou C, Zhang H, Yang F, Qi G, Ma Z Genes (Basel). 2025; 16(2).

PMID: 40004471 PMC: 11855738. DOI: 10.3390/genes16020140.

References

Chou C, Chuang H, Salunke S, Kulp S, Chen C . A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells. Oncotarget. 2015; 6(10):8271-85. PMC: 4480751. DOI: 10.18632/oncotarget.3186. View

Arsham A, Howell J, Simon M . A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem. 2003; 278(32):29655-60. DOI: 10.1074/jbc.M212770200. View

Joyce J, Pollard J . Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009; 9(4):239-52. PMC: 3251309. DOI: 10.1038/nrc2618. View

Jones D, Trowbridge I, Harris A . Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate. Cancer Res. 2006; 66(5):2749-56. DOI: 10.1158/0008-5472.CAN-05-3857. View

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

Lu Q, Gore M, Zhang Q, Camenisch T, Boast S, Casagranda F . Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature. 1999; 398(6729):723-8. DOI: 10.1038/19554. View

Lonser R, Glenn G, Walther M, Chew E, Libutti S, Linehan W . von Hippel-Lindau disease. Lancet. 2003; 361(9374):2059-67. DOI: 10.1016/S0140-6736(03)13643-4. View

Hanna S, Krishnan B, Bailey S, Moschos S, Kuan P, Shimamura T . HIF1α and HIF2α independently activate SRC to promote melanoma metastases. J Clin Invest. 2013; 123(5):2078-93. PMC: 3635738. DOI: 10.1172/JCI66715. View

Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T . Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. Cancer Res. 2007; 67(9):4157-63. DOI: 10.1158/0008-5472.CAN-06-2355. View

10.

Liu Y, Liu Y, Yan X, Xu Y, Luo F, Ye J . HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT. Tumour Biol. 2014; 35(8):8103-14. DOI: 10.1007/s13277-014-2056-0. View

11.

Brugarolas J, Vazquez F, Reddy A, Sellers W, Kaelin Jr W . TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell. 2003; 4(2):147-58. DOI: 10.1016/s1535-6108(03)00187-9. View

12.

Jaakkola P, Mole D, Tian Y, Wilson M, Gielbert J, Gaskell S . Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001; 292(5516):468-72. DOI: 10.1126/science.1059796. View

13.

Kaelin Jr W . Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. Cold Spring Harb Symp Quant Biol. 2011; 76:335-45. PMC: 4197849. DOI: 10.1101/sqb.2011.76.010975. View

14.

Cox T, Rumney R, Schoof E, Perryman L, Hoye A, Agrawal A . The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature. 2015; 522(7554):106-110. PMC: 4961239. DOI: 10.1038/nature14492. View

15.

Vaupel P, Mayer A . Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007; 26(2):225-39. DOI: 10.1007/s10555-007-9055-1. View

16.

Zhang H, Wong C, Wei H, Gilkes D, Korangath P, Chaturvedi P . HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene. 2011; 31(14):1757-70. PMC: 3223555. DOI: 10.1038/onc.2011.365. View

17.

Nandal A, Ruiz J, Subramanian P, Ghimire-Rijal S, Sinnamon R, Stemmler T . Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2. Cell Metab. 2011; 14(5):647-57. PMC: 3361910. DOI: 10.1016/j.cmet.2011.08.015. View

18.

Angelillo-Scherrer A, de Frutos P, Aparicio C, Melis E, Savi P, Lupu F . Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med. 2001; 7(2):215-21. DOI: 10.1038/84667. View

19.

Brown J, Giaccia A . The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 1998; 58(7):1408-16. View

20.

Higgins D, Kimura K, Bernhardt W, Shrimanker N, Akai Y, Hohenstein B . Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007; 117(12):3810-20. PMC: 2082142. DOI: 10.1172/JCI30487. View